The U.S. Federal Trade Commission wants more information about the proposed $4 billion tie-up of BTG (LON:BTG) and Boston Scientific (NYSE:BSX), but the companies said they still expect the merger to close on schedule in mid-2019. In a regulatory filing today, Marlborough, Mass.-based Boston Scientific said yesterday’s FTC request “is focused on the beads businesses of Boston Scientific and […]
Boston Scientific launches AdVance XP male stress urinary incontinence sling
Boston Scientific (NYSE:BSX) said late last week that it launched its AdVance XP male sling system intended to treat male stress urinary incontinence. The newly launched next-gen device includes a redesign intended to improve ease of placement and stability, and is available in longer sling lengths, the Marlborough, Mass.-based company said. “I believe the Advance XP Male […]
3M names CEO Roman as board chair | Personnel Moves – February 7, 2019
3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]
Boston Scientific shares up on Q4, 2018 earnings beat
Shares in Boston Scientific (NYSE:BSX) have risen slightly this morning after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street. The Marlborough, Mass.-based company posted profits of $386 million, or 27¢ per share, on sales of approximately $2.6 billion for the three months ended December 31, seeing […]
Boston Sci joins cyber-physical R&D collaborative
Boston Scientific (NYSE:BSX) has joined PracticePoint, a membership-based, cyber-physical medtech R&D and commercialization alliance founded by Worcester (Mass.) Polytechnic Institute (WPI). PracticePoint is an agile, scalable collaborative research facility featuring point-of-practice clinical suites — including a residential suite, rehabilitative care suite, controlled care suite, and surgical imaging suite — co-located with engineering and manufacturing capabilities and […]
Boston Scientific launches Spectra WaveWriter SCS in Europe
Boston Scientific (NYSE:BSX) said today that it launched its Spectra WaveWriter spinal cord stimulator, intended for treating chronic pain, in Europe. The Marlborough, Mass.-based company said that its Spectra WaveWriter is designed to deliver electrical pulses of varying frequency, pulse width and amplitude to the spinal cord. Boston Scientific touted the device as the first and only […]
Judge awards plaintiffs’ attorneys $366 million in Boston Sci pelvic mesh cases
Attorneys representing thousands of plaintiffs who sued Boston Scientific (NYSE:BSX) over alleged pelvic mesh injuries will receive $366 million, or 5% of the total recoveries in the cases. U.S. District Court Judge Joseph Goodwin in the Southern District of West Virginia wrote in a pretrial order that plaintiffs’ attorneys were “required to spend tens of […]
Boston Scientific pulls Agile biliary stent on migration reports
Boston Scientific (NYSE:BSX) is initiating a voluntary select recall of its Agile biliary RX fully covered stents over issues with device migrations, according to a recently posted field safety notice. The Marlborough, Mass.-based company said that it became aware of a higher than anticipated rate of stent migrations, which can require additional interventions and re-stenting “due […]
Boston Scientific closes Millipede buyout
Boston Scientific (NYSE:BSX) announced that it has completed its acquisition of Iris transcatheter annuloplasty ring developer Millipede (Santa Rosa, Calif.). The company announced the acquisition plan in December last year. The deal was worth approximately $325 million with the opportunity for an additional $125 million based on commercial milestone. The company said in December that […]
Boston Scientific touts 4-year Rezūm BPH treatment trial data
Boston Scientific (NYSE:BSX) last Friday released results from a clinical trial of its Rezūm benign prostatic hyperplasia device, touting durable results and the preservation of sexual function at four years post-treatment. Results from the trial are set to be published in the journal Urology, and have already been published online, the Marlborough, Mass.-based company said. “This […]
Edwards Lifesciences settlement with Boston Scientific lets Neovasc off the hook
Last week’s legal win for Boston Scientific (NYSE:BSX) in its years-long patent battle with Edwards Lifesciences (NYSE:EW) was also a win for Neovasc (NSDQ:NVCN), that company said today. As part of a settlement deal worked out between Irvine, Calif.-based Edwards and Marlborough, Mass.-based Boston Scientific, the Federal Court of Canada dismissed a lawsuit brought by Edwards against Boston, […]
- 1
- 2
- 3
- …
- 136
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube